Cognex Corp: Form 10-K for the period ended Dec 31, 2017
Filed with the SEC on Feb 15, 2018 and accepted by EDGAR at Feb 15, 2018, 16:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2017-01-01 to 2017-12-31 | $168.7m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2017-01-01 to 2017-12-31 | $579.3m | us-gaap:GrossProfit |
| Research and development | 12 months2017-01-01 to 2017-12-31 | $99.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2017-01-01 to 2017-12-31 | $220.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2017-01-01 to 2017-12-31 | $259.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2017-01-01 to 2017-12-31 | $89.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2017-01-01 to 2017-12-31 | $177.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2017-01-01 to 2017-12-31 | $0.99 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2017-01-01 to 2017-12-31 | $1.02 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2017-01-01 to 2017-12-31 | 179,551,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2017-01-01 to 2017-12-31 | $224.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2017-01-01 to 2017-12-31 | $28.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2017-01-01 to 2017-12-31 | $29.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2017-01-01 to 2017-12-31 | $123.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-12-31 | $106.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-12-31 | $630.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-12-31 | $1.29bn | us-gaap:Assets |
| Current liabilities | At period end2017-12-31 | $113.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-12-31 | $192.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-12-31 | $1.10bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000851205-18-000004. Last ingested by Listed: Nov 10, 2026, 23:02 ET. Listed shows no prices and gives no investment advice.